About EXOSOMM
EXOSOMM is a Healthcare company based in Safed (Israel) founded in 2021 by Netta Granot, Yaffa Elbaum-Shiff, and Regina Golan-Gerstl. Developer of a novel food product that contains patent-based milk exosomes. It operates in the Healthcare and Consumer sectors. EXOSOMM has raised $100 thousand across 1 funding round from investors including AgFunder and Go Grow. Its chief executive, as recorded, is Netta Granot. Its focus areas include Food and Agriculture Tech, Food Tech, Novel Foods and Food Ingredients. Its competitors include Remilk, Wilk and Mybiotics; 2 of its 3 listed competitors have raised funding.
Company details
EXOSOMM was founded in 2021 in Safed, Israel, within the biotechnology and nutraceutical sector. A novel food product incorporating patent-based milk exosomes is developed by the company. Nutritional solutions targeted at Inflammatory Bowel Diseases (IBD) are provided, with effects that are therapeutic and anti-inflammatory against colitis. Operations focus on research and product formulation for health applications in gastroenterology.
- Headquarters Safed, Israel
- Founders Netta Granot, Yaffa Elbaum-Shiff, Regina Golan-Gerstl
- SectorsHealthcareConsumer
- Email••••••••
- Website exosomm.com
- Social LinkedIn Facebook
- Total Equity Funding$100K (USD)
in 1 rounds
- Latest Funding Round$100K (USD), Seed
May 2023
- InvestorsAgFunder
& 1 more
Funding Insights of EXOSOMM
EXOSOMM has successfully raised a total of $100K through 1 strategic funding round. The most recent funding activity was a Seed round of $100 thousand completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $100,000
- Total Rounds 1
- Last Round Seed — $100,000
- First Round $100,000
(May 2023)
- Investors Count 2
All 1 funding rounds of EXOSOMM with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in EXOSOMM
EXOSOMM has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include AgFunder and Go Grow.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund focused on ag-tech and food-tech sectors | agfunder.com | San Francisco, United States | ||
Startups in agtech and foodtech sectors are accelerated by GROW. | gogrow.co | Singapore, Singapore |
Investor details for EXOSOMM
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EXOSOMM
3 people are tracked at EXOSOMM (3 in leadership).
| Name | Role | Group |
|---|---|---|
Netta Granot | Co-Founder & CEO | Leadership |
Yaffa Elbaum-Shiff | Co-Founder | Leadership |
Regina Golan-Gerstl | Co-Founder | Leadership |
Complete people profiles for EXOSOMM
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of EXOSOMM
2 dated milestones of EXOSOMM across 2 years, from founding to its latest funding, stage changes and deals.
- Founded EXOSOMM is founded.
- Funding First funding round of $100K.
Competitors of EXOSOMM
EXOSOMM has 3 listed competitors in our database, 2 of them funded. They include Remilk, Wilk and Mybiotics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| remilk.com | 2019 | Tel Aviv, Israel | $131.3M | Animal-free dairy products are created via microbial fermentation. | ||
| wilkismilk.com | 2020 | Rehovot, Israel | $3.5M | Milk ingredients are manufactured by Wilk in Israel. | ||
| mybiotix.com | 2014 | Ness Ziona, Israel | Developing live biotherapeutic products using microbiome technologies for health. |
Detailed competitors of EXOSOMM
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EXOSOMM
EXOSOMM was founded in 2021 and raised its 1st funding round 2 years after it was founded.
EXOSOMM is headquartered in Safed, Israel. It is registered at Safed, Northern District, Israel.
Netta Granot is the CEO of EXOSOMM, as recorded in our data. They have also founded this company.
EXOSOMM is a funded company, having raised a total of $100K across 1 funding round to date. The company's 1st funding round was a Seed of $100K, raised on May 2023.
EXOSOMM was founded in 2021 in Safed, Israel, within the biotechnology and nutraceutical sector. A novel food product incorporating patent-based milk exosomes is developed by the company. Nutritional solutions targeted at Inflammatory Bowel Diseases (IBD) are provided, with effects that are therapeutic and anti-inflammatory against colitis. Operations focus on research and product formulation for health applications in gastroenterology.